Sign In
Buy PNTG
The Pennant Group Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 74.63. In total, the insiders bought 818.02K and sold 14.26K PNTG shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
74.63 |
| ● Buy | 818.02K shares |
| ● Sell | 14.26K shares |
|
92% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 22, 2026 Sell |
Guerisoli Brent Chief Executive Officer |
2 254 Value: $79.1K |
||
|
May 22, 2026 Sell |
Guerisoli Brent Chief Executive Officer |
22 Value: $767 |
||
|
May 22, 2026 Buy |
Guerisoli Brent Chief Executive Officer |
4 463 Value: $17.1K |
||
|
May 22, 2026 Buy |
Guerisoli Brent Chief Executive Officer |
4 463 Value: $17.1K |
||
|
May 22, 2026 Sell |
Guerisoli Brent Chief Executive Officer |
2 032 Value: $71.3K |
||
|
May 22, 2026 Sell |
Guerisoli Brent Chief Executive Officer |
200 Value: $7K |
||
|
May 22, 2026 Buy |
Guerisoli Brent Chief Executive Officer |
4 463 Value: $17.1K |
||
|
May 22, 2026 Buy |
Guerisoli Brent Chief Executive Officer |
4 463 Value: $17.1K |
||
|
May 16, 2026 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
35 000 Value: $1.06M |
||
|
May 16, 2026 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
35 000 Value: $1.06M |
||
|
May 16, 2026 Buy |
Steik Jason Paul Chief Clinical Officer |
35 000 Value: $1.06M |
||
|
May 16, 2026 Buy |
Steik Jason Paul Chief Clinical Officer |
35 000 Value: $1.06M |
||
|
Apr 15, 2026 Buy |
Snapper Suzanne D. Director |
1 900 Value: $58.0K |
||
|
Apr 15, 2026 Buy |
Smith Barry M Director |
1 900 Value: $58.0K |
||
|
Apr 15, 2026 Buy |
Morris Gregory K Sr. Director |
1 900 Value: $58.0K |
||
|
Apr 15, 2026 Buy |
Christensen Christopher R. Director |
1 900 Value: $58.0K |
||
|
Apr 15, 2026 Buy |
Nackel John G. Director |
1 900 Value: $58.0K |
||
|
Apr 15, 2026 Buy |
Lamb Scott E Director |
2 400 Value: $73.3K |
||
|
Apr 15, 2026 Buy |
Covey Stephen M R Director |
1 900 Value: $58.0K |
||
|
Mar 05, 2026 Buy |
Guerisoli Brent Chief Executive Officer |
45 000 Value: $1.50M |
||
|
Mar 05, 2026 Buy |
Steik Jason Paul Chief Clinical Officer |
26 000 Value: $865.8K |
||
|
Mar 05, 2026 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
30 000 Value: $999.0K |
||
|
Mar 05, 2026 Buy |
Gochnour John J Chief Operating Officer |
41 000 Value: $1.37M |
||
|
Mar 05, 2026 Buy |
Walbom Lynette Chief Financial Officer |
34 000 Value: $1.13M |
||
|
Mar 03, 2026 Buy |
Walbom Lynette Chief Financial Officer |
8 025 Value: $265.0K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
